Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Nature Communications|April 17, 2024
Improvement of immune dysregulation in individuals with long COVID at 24-months following SARS-CoV-2 infectionChansavath Phetsouphanh, Brendan Jacka, Sara Ballouz, et al.
Ebiomedicine|November 29, 2024
Bivalent Omicron BA.1 vaccine booster increases memory B cell breadth and neutralising antibodies against emerging SARS-CoV-2 variantsLok Bahadur Shrestha, Katie Tungatt, Anupriya Aggarwal, et al.
NPJ Vaccines|December 1, 2021
A single dose, BCG-adjuvanted COVID-19 vaccine provides sterilising immunity against SARS-CoV-2 infectionClaudio Counoupas, Matt D Johansen, Alberto O Stella, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 2, 2025
Affinity maturation endows potent activity onto class 6 SARS-CoV-2 broadly neutralizing antibodiesOhan Mazigi, David B Langley, Jake Y Henry, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 20, 2023
A broad-spectrum macrocyclic peptide inhibitor of the SARS-CoV-2 spike proteinVito Thijssen, Daniel L Hurdiss, Oliver J Debski-Antoniak, et al.
The Journal of Clinical Investigation|November 17, 2025
P selectin promotes SARS-CoV-2 interactions with platelets and the endotheliumCesar L Moreno, Fernanda Vs Castanheira, Alberto Ospina Stella, et al.
Nature Communications|February 8, 2023
Broadly neutralizing SARS-CoV-2 antibodies through epitope-based selection from convalescent patientsRomain Rouet, Jake Y Henry, Matt D Johansen, et al.
Cell Reports. Medicine|June 2, 2022
SARS-CoV-2 Omicron variant escapes neutralizing antibodies and T cell responses more efficiently than other variants in mild COVID-19 convalescentsPablo Garcia-Valtanen, Christopher M Hope, Makutiro G Masavuli, et al.
Plos Medicine|July 6, 2021
SARS-CoV-2 neutralizing antibodies: Longevity, breadth, and evasion by emerging viral variantsFiona Tea, Alberto Ospina Stella, Anupriya Aggarwal, et al.
Pageof 6